Literature DB >> 11739680

Cross-presentation of human cytomegalovirus pp65 (UL83) to CD8+ T cells is regulated by virus-induced, soluble-mediator-dependent maturation of dendritic cells.

Géraldine Arrode1, Claire Boccaccio, Jean-Pierre Abastado, Christian Davrinche.   

Abstract

Cytotoxic CD8+ T lymphocytes (CTL) directed against the matrix protein pp65 are major effectors in controlling infection against human cytomegalovirus (HCMV), a persistent virus of the Betaherpesvirus family. We previously suggested that cross-presentation of pp65 by nonpermissive dendritic cells (DCs) could overcome viral strategies that interfere with activation of CTL (G. Arrode, C. Boccaccio, J. Lule, S. Allart, N. Moinard, J. Abastado, A. Alam, and C. Davrinche, J. Virol. 74:10018-10024, 2000). It is well established that mature DCs are very potent in initiating T-cell-mediated immunity. Consequently, the DC maturation process is a key step targeted by viruses in order to avoid an immune response. Here, we report that immature DCs maintained in coculture with infected human (MRC5) fibroblasts acquired pp65 from early-infected cells for cross-presentation to specific HLA-A2-restricted CTL. In contrast, coculture of DCs in the presence of late-infected cells decreased their capacity to stimulate CTL. Analyses of DC maturation after either coculture with infected MRC5 cells or incubation with infected-cell-conditioned medium revealed that acquisition of a mature phenotype was a prerequisite for efficient stimulation of CTL and that soluble factors secreted by infected cells were responsible for both up and down regulation of CD83 expression on DCs. We identified transforming growth factor beta1 secreted by late HCMV-infected cells as one of these down regulating mediators. These findings suggest that HCMV has devised another means to compromise immune surveillance mechanisms. Together, our data indicate that recognition of HCMV-infected cells by DCs has to occur early after infection to avoid immune evasion and to allow generation of anti-HCMV CTL.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11739680      PMCID: PMC135703          DOI: 10.1128/jvi.76.1.142-150.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

Review 1.  Immunobiology of dendritic cells.

Authors:  J Banchereau; F Briere; C Caux; J Davoust; S Lebecque; Y J Liu; B Pulendran; K Palucka
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10).

Authors:  S V Kotenko; S Saccani; L S Izotova; O V Mirochnitchenko; S Pestka
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

3.  A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2.

Authors:  V S Goldmacher; L M Bartle; A Skaletskaya; C A Dionne; N L Kedersha; C A Vater; J W Han; R J Lutz; S Watanabe; E D Cahir McFarland; E D Kieff; E S Mocarski; T Chittenden
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

Review 4.  The immunogenicity of human and murine cytomegaloviruses.

Authors:  M J Reddehase
Journal:  Curr Opin Immunol       Date:  2000-08       Impact factor: 7.486

5.  Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus.

Authors:  S Riegler; H Hebart; H Einsele; P Brossart; G Jahn; C Sinzger
Journal:  J Gen Virol       Date:  2000-02       Impact factor: 3.891

6.  Requirement of mature dendritic cells for efficient activation of influenza A-specific memory CD8+ T cells.

Authors:  M Larsson; D Messmer; S Somersan; J F Fonteneau; S M Donahoe; M Lee; P R Dunbar; V Cerundolo; I Julkunen; D F Nixon; N Bhardwaj
Journal:  J Immunol       Date:  2000-08-01       Impact factor: 5.422

7.  Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity.

Authors:  M Kruse; O Rosorius; F Krätzer; G Stelz; C Kuhnt; G Schuler; J Hauber; A Steinkasserer
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

8.  Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells.

Authors:  B Sauter; M L Albert; L Francisco; M Larsson; S Somersan; N Bhardwaj
Journal:  J Exp Med       Date:  2000-02-07       Impact factor: 14.307

9.  Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).

Authors:  N A Fanger; C R Maliszewski; K Schooley; T S Griffith
Journal:  J Exp Med       Date:  1999-10-18       Impact factor: 14.307

Review 10.  Viral mechanisms of immune evasion.

Authors:  A Alcami; U H Koszinowski
Journal:  Immunol Today       Date:  2000-09
View more
  11 in total

1.  Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus.

Authors:  Laura Hertel; Vashti G Lacaille; Herbert Strobl; Elizabeth D Mellins; Edward S Mocarski
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

Review 2.  Herpesvirus interference with major histocompatibility complex class II-restricted T-cell activation.

Authors:  Emmanuel J Wiertz; Robert Devlin; Helen L Collins; Maaike E Ressing
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

3.  Antigen cross-presentation by dendritic cell subsets: one general or all sergeants?

Authors:  Stefan Nierkens; Jurjen Tel; Edith Janssen; Gosse J Adema
Journal:  Trends Immunol       Date:  2013-03-27       Impact factor: 16.687

4.  Interplay between modified vaccinia virus Ankara and dendritic cells: phenotypic and functional maturation of bystander dendritic cells.

Authors:  María F Pascutti; Ana M Rodríguez; Juliana Falivene; Luis Giavedoni; Ingo Drexler; M Magdalena Gherardi
Journal:  J Virol       Date:  2011-03-16       Impact factor: 5.103

5.  Processing and presentation of murine cytomegalovirus pORFm164-derived peptide in fibroblasts in the face of all viral immunosubversive early gene functions.

Authors:  Rafaela Holtappels; Natascha K A Grzimek; Christian O Simon; Doris Thomas; Doris Dreis; Matthias J Reddehase
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

Review 6.  Viral effects on the content and function of extracellular vesicles.

Authors:  Nancy Raab-Traub; Dirk P Dittmer
Journal:  Nat Rev Microbiol       Date:  2017-06-26       Impact factor: 60.633

7.  Specific requirements for Vgamma9Vdelta2 T cell stimulation by a natural adenylated phosphoantigen.

Authors:  Pierre Vantourout; Jayati Mookerjee-Basu; Corinne Rolland; Frédéric Pont; Hélène Martin; Christian Davrinche; Laurent O Martinez; Bertrand Perret; Xavier Collet; Christian Périgaud; Suzanne Peyrottes; Eric Champagne
Journal:  J Immunol       Date:  2009-08-26       Impact factor: 5.422

Review 8.  Interplay between human cytomegalovirus and dendritic cells in T cell activation.

Authors:  Hélène Martin; Marie Mandron; Christian Davrinche
Journal:  Med Microbiol Immunol       Date:  2008-02-09       Impact factor: 3.402

9.  Gut dendritic cell activation links an altered colonic microbiome to mucosal and systemic T-cell activation in untreated HIV-1 infection.

Authors:  S M Dillon; E J Lee; C V Kotter; G L Austin; S Gianella; B Siewe; D M Smith; A L Landay; M C McManus; C E Robertson; D N Frank; M D McCarter; C C Wilson
Journal:  Mucosal Immunol       Date:  2015-04-29       Impact factor: 7.313

10.  Peyer's patch dendritic cells process viral antigen from apoptotic epithelial cells in the intestine of reovirus-infected mice.

Authors:  Marina N Fleeton; Nikhat Contractor; Francisco Leon; J Denise Wetzel; Terence S Dermody; Brian L Kelsall
Journal:  J Exp Med       Date:  2004-07-19       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.